Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Critical Reviews in Oncology/Hematology|June 25, 2024
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancerElena Guerini-Rocco, Konstantinos Venetis, Giulia Cursano, et al.
Cancers|June 19, 2024
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial IntelligenceMariia Ivanova, Carlo Pescia, Dario Trapani, et al.
Pharmacogenomics|March 5, 2024
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratoriesFrancesco Pepe, Konstantinos Venetis, Giulia Cursano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2025
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impactKonstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo, et al.
Pathologica|April 9, 2026
PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
The Lancet. Oncology|March 6, 2025
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trialGiulia Marvaso, Giulia Corrao, Mattia Zaffaroni, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Critical Reviews in Oncology/Hematology|August 18, 2023
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide surveyNicola Fusco, Mariia Ivanova, Chiara Frascarelli, et al.
Pageof 2